scorecardresearch
Add as a preferred source on Google
Tuesday, November 25, 2025
TopicPharmaceutical companies

Topic: Pharmaceutical companies

After govt move to review remdesivir MRP, pharma firms say will cut it to under Rs 3,500/vial

Remdesivir is one of the most sought-after experimental drugs for the treatment of Covid patients and part of the country’s treatment protocol.

Cipla, Sun Pharma, Lupin on drug price watchdog’s new list of firms ‘overcharging consumers’

NPPA has issued a list of  ‘overcharging cases’ under litigation, which includes matters dating back to 1997 & those where firms have moved court against the allegations.

Why there’s no stopping the spectacular rise of this Indian pharma company

The optimism is stemming from the company’s capacity-expansion plans and potential to win more business as India cuts its reliance on Chinese suppliers.

Pharma companies to cut prices of news drugs by 51% to access Chinese market

Patients will only need to pay a small fraction of the cost of these drugs as the lion’s share of the bill will be footed by China’s $373 billion national medical insurance fund.

High demand, strict inspections — how Biden’s presidency could impact India’s pharma sector

US is the biggest market for Indian pharmaceutical companies and Biden's presidency is expected to bring with it some favourbable changes that could have a long-ranging impact.

Govt repeats warning to pharma firms, says don’t ‘promote products in unethical ways’

In a letter to pharma organisations, govt mentioned a complaint against an event to be held by ‘Indian Psychotropic Society’. Industry members say they have never heard the name.

US FDA warns pharma giant Mylan over poor quality control at its Telangana plant

US FDA inspected Mylan’s plant in Pashamylaram, Telangana, and found it hadn’t taken proper precautions to ensure solvents didn’t contain impurities.

Modi govt to form standing committee to prevent drugmakers from evading price control

Representatives from NPPA, CDSCO and DGHS to be part of the standing committee, which will have mandate to approve the drug discontinuation applications.

Glenmark’s favipiravir under govt scanner for ‘false claims’, cost, DCGI seeks clarification

Complaint by MP to DCGI  also highlights that the cost proposed by Glenmark is ‘definitely not in the interest of the poor, lower middle class and middle-class people of India’.

2 die at pharma plant after Vizag sees another gas leak in less than 2 months

Four people were hospitalised after benzene gas leaked at the Sainor Life Sciences company. The cause of the leak is yet to be determined.

On Camera

India shouldn’t copy Taiwan’s currency playbook. It will only lead to instability

Should India opt for a deliberately weakened rupee, it risks compromising its greatest asset: a vast and expanding domestic consumer market.

172 countries & counting, India looks to hit new record in rice exports. But there’s a flip side

The industry forecasts exports are set to grow 16% in 2025-26, boosted by surplus domestic production and a drive to push into 26 underserved global markets with strong potential.

India and France to jointly manufacture HAMMER air-to-surface missile

Indigenisation level will progressively increase up to 60 percent with key sub-assemblies, electronics and mechanical parts being manufactured locally.

A tribute to Tejas. India’s delay culture is the real enemy in the skies

It is a brilliant, reasonably priced, and mostly homemade aircraft with a stellar safety record; only two crashes in 24 years since its first flight. But its crash is a moment of introspection.